Product logins

Find logins to all Clarivate products below.


Rheumatoid arthritis (RA) is a complex, chronic autoimmune condition that causes pain, stiffness, and swelling that, in moderate to severe cases, limits motion and functionality. The TreatmentTrends®: Rheumatoid Arthritis 2015 (EU5) report provides valuable insight into the treatment dynamics among more than 200 French, German, Italian, Spanish, and U.K. rheumatologists through comprehensive primary research methods and how these treatment dynamics have evolved in recent years. This report covers in detail the use of biological products prescribed for RA, and explores rheumatologists’ awareness, trial, and usage of currently available brands, as well as their familiarity with and interest in key emerging therapies.

Related Market Assessment Reports

Report
Rheumatoid Arthritis – Landscape & Forecast – Disease Landscape & Forecast (G7)
Although TNF-alpha inhibitors remain the most widely prescribed biologics for rheumatoid arthritis (RA) refractory to conventional DMARD treatment (the first-line standard of care), the RA drug…
Report
Rheumatoid Arthritis | Disease Landscape & Forecast | G7 | 2025
Although TNF-alpha inhibitors remain the most widely prescribed biologics for rheumatoid arthritis (RA) refractory to conventional DMARD treatment (the first-line standard of care), the RA drug…
Report
Rheumatoid Arthritis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Rheumatoid Arthritis (US)
The treatment of rheumatoid arthritis (RA) typically begins with cost-effective conventional DMARDs (cDMARDs) such as methotrexate or hydroxychloroquine. For patients who fail cDMARD treatment or…
Report
Rheumatoid Arthritis – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key rheumatoid arthritis patient populations, covering 171 countries and…
Report
Rheumatoid Arthritis – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of rheumatoid arthritis (RA) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RA for each…